| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/18/2008 | US20080311587 Use of Genetic Information to Detect a Predisposition for Bone Density Conditions |
| 12/18/2008 | US20080311586 Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment |
| 12/18/2008 | US20080311585 System and method for multiplex liquid handling |
| 12/18/2008 | US20080311584 desirable for identification of animals having or having a predisposition for increased muscle mass that can be used to produce food products, including bovine, porcine, ovine, avian and piscine species; influence hypertrophic and hyperplastic muscle development |
| 12/18/2008 | US20080311583 Chromosome manipulation method |
| 12/18/2008 | US20080311582 Methods Using Pores |
| 12/18/2008 | US20080311581 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| 12/18/2008 | US20080311580 Novel genes encoding proteins involved in proanthocyanidin synthesis |
| 12/18/2008 | US20080311579 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 12/18/2008 | US20080311578 System for screening eukaryotic membrane proteins |
| 12/18/2008 | US20080311577 Method for the Identification of Sulfo-Oxidizing Bacteria and for the Monitoring of Elemental Sulfur in the Environment |
| 12/18/2008 | US20080311576 Replication competent hepatitis C virus and methods of use |
| 12/18/2008 | US20080311575 Modulation of Muci-Dependent Anti-Estrogen Resistance |
| 12/18/2008 | US20080311574 Novel Missense Mutations and Single Nucleotide Polymorphisms in the Rabphillin-3A-Like Gene and Uses Thereof |
| 12/18/2008 | US20080311573 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 12/18/2008 | US20080311572 Methods and Compositions For Correlating Ccl3l1/Ccr5 Genotypes With Disorders |
| 12/18/2008 | US20080311571 Nucleic Acid Fragments for Detecting Nucleic Acid and Method for Detecting Nucleic Acid |
| 12/18/2008 | US20080311570 Cancer screening method |
| 12/18/2008 | US20080311569 Method for quantitative measurement of gene expression for indentifying individuals at risk for bronchogenic carcinoma |
| 12/18/2008 | US20080311568 Compositions and Methods for Nucleic Acid Analysis of Sequences with Insertions or Deletions |
| 12/18/2008 | US20080311567 Tumor Markers for Use in the Diagnosis of Colorectal Carcinomas and/or Metastases Originating Therefrom |
| 12/18/2008 | US20080311566 Method for Quantification of Methylated Dna |
| 12/18/2008 | US20080311565 Methods and Kits for Detecting Germ Cell Genomic Instability |
| 12/18/2008 | US20080311564 Sequences and Methods for Detection of Cytomegalovirus |
| 12/18/2008 | US20080311563 Methods for selecting medications |
| 12/18/2008 | US20080311562 Nucleic Acid Sequencing |
| 12/18/2008 | US20080311561 Kits and Method For Detecting Human Papilloma Virus With Oligo Nucleotide Bead Array |
| 12/18/2008 | US20080311560 hybridization assay probes, helper probes, and/or amplification primers; kits |
| 12/18/2008 | US20080311559 using amplification oligomers and polymerase; hybridization; efficient and sensitive; useful in determining efficacy of vaccination |
| 12/18/2008 | US20080311558 Using replication of intelligent primers (ribosomal RNA or house keeping oligonucleotides) to identify, classify and diagnose infection |
| 12/18/2008 | US20080311557 Device, kit and method for hookworm antigen capture and detection |
| 12/18/2008 | US20080311556 Sense Antiviral Compound and Method for Treating Ssrna Viral Infection |
| 12/18/2008 | US20080311555 In Vitro Root-Nematode Assay in Multi-Well Plates |
| 12/18/2008 | US20080311185 Deregulated Genes and/or Processes in Inflammatory Arthritis |
| 12/18/2008 | US20080311159 Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease |
| 12/18/2008 | US20080311150 Novel sequences encoding hepatitis C virus glycoproteins |
| 12/18/2008 | US20080311132 Human Complement C3 Derivates with Cobra Venom Factor-Like Function |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/18/2008 | US20080311116 Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof |
| 12/18/2008 | US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311102 Nucleic acid molecule that encodes the MGAT-X1 protein; pharmaceutical composition containing the nucleic acid or its expression vector |
| 12/18/2008 | US20080311094 Isolated Liver Stem Cells |
| 12/18/2008 | US20080311092 Murine Stem Cells and Applications Thereof |
| 12/18/2008 | US20080311091 Engineered Dopamine Neurons and Uses Thereof |
| 12/18/2008 | US20080311090 Methods for inhibition of proliferative disease, including hepatocellular carcinoma |
| 12/18/2008 | US20080311041 Water-Soluble, Fluorescent Compounds for Detection of Potassium Ions |
| 12/18/2008 | US20080311040 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| 12/18/2008 | US20080311039 Therapeutic and Prognostic Factor Yy1 in Human Cancer |
| 12/18/2008 | US20080311037 Compounds which bind PSMA and uses thereof |
| 12/18/2008 | US20080308723 Method of non-targeted complex sample analysis |
| 12/18/2008 | DE102007031137A1 Real-time detection of nucleic acid targets, comprises providing a primer containing a sequence-target binding sequence to amplify nucleic acid, introducing a fluorophore and providing a probe for detection, which carries a fluorophore |
| 12/18/2008 | DE102007027654A1 Verfahren zum Nachweis von Nukleinsäuren A method for detecting nucleic acids |
| 12/18/2008 | DE102007027619A1 Biosensor Biosensor |
| 12/18/2008 | DE102004050139B4 Mikrofluidprozessor und Verfahren zur Durchführung einer Polymerasekettenreaktion Microfluid processor and method for performing a polymerase chain reaction |
| 12/18/2008 | CA2713024A1 Lipoprotein surfactant |
| 12/18/2008 | CA2710426A1 Allelic determination |
| 12/18/2008 | CA2694030A1 Composition for measuring the binding affinity between nucleic acid and test substance, and use thereof |
| 12/18/2008 | CA2690909A1 Peripherical tissue sample containing cells expressing the 5htr2c and/or adars as markers of the alteration of the mechanism of the 5htr2c mrna editing and its applications |
| 12/18/2008 | CA2690898A1 Biomarkers for predicting anti-tnf responsiveness or non-responsiveness |
| 12/18/2008 | CA2690815A1 Targeted cell death |
| 12/18/2008 | CA2690671A1 Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 12/18/2008 | CA2690334A1 Gene expression markers of tumor resistance to her2 inhibitor treatment |
| 12/18/2008 | CA2690267A1 Small cationic antimicrobial peptides |
| 12/18/2008 | CA2690144A1 Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells |
| 12/18/2008 | CA2690043A1 Signal amplification using circular hairpin probes |
| 12/18/2008 | CA2689654A1 Diagnostic test for the detection of early stage liver cancer |
| 12/18/2008 | CA2689638A1 Pde inhibitors for the treatment of hearing impairment |
| 12/18/2008 | CA2689631A1 Genetic markers associated with endometriosis and use thereof |
| 12/18/2008 | CA2689626A1 Methods and processes for calling bases in sequence by incorporation methods |
| 12/18/2008 | CA2689323A1 Process for detecting nucleic acids |
| 12/18/2008 | CA2688644A1 Methods for sequence-directed molecular breeding |
| 12/18/2008 | CA2688256A1 Methods of modulating inflammation and compositions therefore |
| 12/18/2008 | CA2686537A1 Nucleic acid chip for obtaining bind profile of single strand nucleic acid and unknown biomolecule, manufacturing method thereof and analysis method of unknown biomolecule using nucleic acid chip |
| 12/17/2008 | EP2003453A2 Method for detection, determination or prediction of hepatic disorder |
| 12/17/2008 | EP2003450A1 Dry analytical element for lipase measurement |
| 12/17/2008 | EP2003214A2 Reagents, methods, and libraries for bead-based sequencing |
| 12/17/2008 | EP2003213A2 Expression profile of prostate cancer |
| 12/17/2008 | EP2003212A1 In vitro method for diagnosing pathological conditions of male infertility |
| 12/17/2008 | EP2003207A2 Antisense inhibition of PTP1B expression |
| 12/17/2008 | EP2003203A1 Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily |
| 12/17/2008 | EP2003202A2 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/17/2008 | EP2003201A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 12/17/2008 | EP2003200A1 Phage display by novel filamentous bacteriophage |
| 12/17/2008 | EP2003199A1 Glucose dehydrogenase |
| 12/17/2008 | EP2003196A2 Compositions and methods for treating and diagnosing cancer |
| 12/17/2008 | EP2002367A2 System and method for correcting primer extension errors in nucleic acid sequence data |
| 12/17/2008 | EP2002262A2 Devices and methods for detecting cells and other analytes |
| 12/17/2008 | EP2002037A2 Random rnai libraries, methods of generating same, and screening methods utilizing same |
| 12/17/2008 | EP2002036A2 Compositions and methods related to profiling a plurality of cell lines based on peptide binding |
| 12/17/2008 | EP2002022A1 Hpv detection and quantification by real-time multiplex amplification |
| 12/17/2008 | EP2002021A1 Methods for assaying protein-protein interaction |
| 12/17/2008 | EP2002020A2 Single nucleotide polymorphism detection from unamplified genomic dna |
| 12/17/2008 | EP2002018A2 Antisense antiviral compound and method for treating arenavirus infection |
| 12/17/2008 | EP2002017A2 High throughput detection of molecular markers based on restriction fragments |
| 12/17/2008 | EP2002016A2 Method for determining copy number |
| 12/17/2008 | EP2002015A2 Mixture of reversibly inhibited enzymes |
| 12/17/2008 | EP2002014A1 Method for performing prognoses for high-risk breast cancer patients using top2a gene aberrations |
| 12/17/2008 | EP2002013A2 Assessment of reaction kinetics compatibility between polymerase chain reactions |
| 12/17/2008 | EP2002012A1 Methods of treating, reducing and inhibiting the appearance of ageing in the skin |